Drawing for X-FAST

USPTO serial 88299280

X-FAST

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KON, ELISSA GARBER
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with X-FAST?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JULIAN D GONZALEZ

1 DEERPARK DRIVE, SUITE RMONMOUTH JUNCTION, NJ 08852UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Assays for research purposes; Biological and chemical reagents used for non-medical purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits for laboratory or research use in the field of personal wellness; Biological and chemical test kits for laboratory or research use for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; all the foregoing employing the staining of biological samplesACTIVE—
005Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; all the foregoing employing the staining of biological samplesACTIVE—
010Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; all the foregoing employing the staining of biological samplesACTIVE—
044Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Healthcare services; diagnostic services, namely, medical testing for diagnostic purposes; Wellness services, namely, providing mental health and wellness information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and wellness services, all in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical testing services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample, all the foregoing employing the staining of biological samplesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 19, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 19, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 17, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 6, 2022TMBNTTAB RELEASE CASE TO TRADEMARKS—
Apr 6, 2022OP.TOPPOSITION TERMINATED NO. 999999—
Apr 6, 2022OP.DOPPOSITION DISMISSED NO. 999999—
Sep 9, 2019OP.IOPPOSITION INSTITUTED NO. 999999—
Jul 29, 2019ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 19, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 31, 2019ALIEASSIGNED TO LIE—
May 17, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 17, 2019XAECEXAMINER'S AMENDMENT ENTERED—
May 17, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 17, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
May 17, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 28, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 28, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 28, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Mar 22, 2019DOCKASSIGNED TO EXAMINER—
Mar 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 16, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance